Clinuvel Pharmaceuticals Ltd Cash Flow-to-Debt Ratio
Clinuvel Pharmaceuticals Ltd cash flow-to-debt ratio. Clinuvel Pharmaceuticals Ltd (CUV) has a Cash Flow-to-Debt Ratio of 0.61x as of December 2025, meaning its operating cash flow of AU$12.52 Million could theoretically repay 1% of its total liabilities (AU$20.68 Million) in one year. Check CUV cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Clinuvel Pharmaceuticals Ltd (2001–2025)
Cash flow-to-debt ratio of Clinuvel Pharmaceuticals Ltd from 2001 to 2025. Historical debt coverage capacity for Clinuvel Pharmaceuticals Ltd across 24 annual periods. Check total reinvestment intensity of Clinuvel Pharmaceuticals Ltd to assess the company's total reinvestment commitment from operating cash flow.
Clinuvel Pharmaceuticals Ltd Cash Flow-to-Debt Ratio by Year (2001–2025)
Clinuvel Pharmaceuticals Ltd cash flow-to-debt ratio by year from 2001 to 2025. Year-by-year debt coverage analysis for Clinuvel Pharmaceuticals Ltd. For the full cash flow conversion analysis, see CUV cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.33x | AU$41.10 Million | AU$30.94 Million | ▲ +0.8% |
| 2024 | 1.32x | AU$37.05 Million | AU$28.11 Million | ▲ +6.7% |
| 2023 | 1.23x | AU$36.91 Million | AU$29.89 Million | ▼ -40.4% |
| 2022 | 2.07x | AU$39.87 Million | AU$19.25 Million | ▲ +5.7% |
| 2021 | 1.96x | AU$19.26 Million | AU$9.83 Million | ▲ +30.9% |
| 2020 | 1.50x | AU$14.19 Million | AU$9.48 Million | ▼ -58.1% |
| 2019 | 3.57x | AU$18.46 Million | AU$5.17 Million | ▲ +6.6% |
| 2018 | 3.35x | AU$11.69 Million | AU$3.49 Million | ▲ +6.9% |
| 2017 | 3.14x | AU$9.92 Million | AU$3.16 Million | ▲ +243.4% |
| 2016 | -2.19x | AU$-5.04 Million | AU$2.30 Million | ▼ -17.7% |
| 2015 | -1.86x | AU$-4.53 Million | AU$2.44 Million | ▲ +33.3% |
| 2014 | -2.79x | AU$-4.81 Million | AU$1.73 Million | ▲ +20.1% |
| 2013 | -3.49x | AU$-6.89 Million | AU$1.98 Million | ▲ +17.9% |
| 2012 | -4.25x | AU$-10.02 Million | AU$2.36 Million | ▼ -68.3% |
| 2011 | -2.52x | AU$-9.49 Million | AU$3.76 Million | ▲ +34.0% |
| 2010 | -3.82x | AU$-11.78 Million | AU$3.08 Million | ▼ -58.9% |
| 2009 | -2.41x | AU$-10.99 Million | AU$4.56 Million | ▼ -5.8% |
| 2008 | -2.28x | AU$-7.18 Million | AU$3.16 Million | ▲ +32.3% |
| 2007 | -3.36x | AU$-8.18 Million | AU$2.43 Million | ▲ +9.1% |
| 2006 | -3.70x | AU$-11.40 Million | AU$3.08 Million | ▼ -4.1% |
| 2005 | -3.55x | AU$-9.25 Million | AU$2.60 Million | ▲ +17.5% |
| 2004 | -4.31x | AU$-6.00 Million | AU$1.39 Million | ▲ +63.5% |
| 2002 | -11.81x | AU$-2.49 Million | AU$210.83K | ▼ -630.6% |
| 2001 | -1.62x | AU$-514.54K | AU$318.26K | — |